# Lymphoma

Danielle Fishman

---

## Background

- Classically characterized by lymphadenopathy & constitutional “B”
    symptoms: fevers, drenching night sweats and weight loss
- Hodgkin:
    - 10%
    - superficial, nodal disease with orderly spread
    - Bimodal Distribution: 15-35 years and \>50 years; M\>F
    - CD15+, CD30+ (Reed Sternberg cells “owl eyes”)
    - Associated with EBV in immunocompromised patient
- Non-Hodgkin:
    - 90%
    - diffuse, nodal and extranodal disease with
        noncontiguous spread
    - Average 65 years, M>F, 85-90% B-cell
    - Associated with immunodeficiency (HIV, post-transplant), autoimmune
        disease, infection (EBV, HTLV-1, H pylori, HCV, Borrelia, C
        psittacosis, Coxiella)

## General Evaluation

- History
    - B symptoms; pruritus (10-15% of pt with HL); history of radiation
- Physical Exam
    - Head & neck, tonsils, axilla, testes, liver, spleen
    - Lymphadenopathy: painless, firm, fixed, >1cm
- Lab tests:
    - CBC, CMP, LDH, Uric Acid, Phosphorus
    - Consider HBV, HCV, HIV, EBV, Quant gold, Treponemal Ab, ANA
- Imaging:
    - CT chest, abdomen, pelvis
    - Most will eventually need PET-CT; MRI brain if neuro symptoms
- Consider LP for NHL with high risk of CNS involvement or presence of
    neurological symptoms
    - Risk factors: Burkitt, Lymphoblastic, testicular involvement,
        double/triple hit
    - Multiple LPs may be required to diagnose CNS lymphoma
- Diagnosis requires tissue
    - Excisional Lymph node biopsy (Surg Onc Consult)
    - Core biopsy (CT guided procedure consult)
    - Of note, steroids may impact value of biopsy results

- Lugano Classification: staging of lymphoma
    - I. 1 LN region or single extra lymphatic organ/site without nodal involvement
    - II. >2 LN regions, same side of diaphragm
    - III. LN regions on both sides of diaphragm
    - IV. Disseminated disease w/ 1+ extralymphatic organ

- Hodgkin:
    - IPS negative prognostic calculator: albumin <4, hemoglobin <10.5,
        male, stage IV disease, age>45, WBC count> 15K,
        lymphocyte <8% of WBC count
- Non-Hodgkin:
    - Good prognosis: Follicular, Marginal Zone, Mycosis
        Fungoides/Sezary Syndrome
    - Poor prognosis: DLBCL – can arise from low grade lymphoma
        Richter transformation), Double/Triple Hit: bcl-2, bcl-6,
        or myc aberrations, Mantle Cell, Burkitt, Lymphoblastic
        Lymphoma, and Anaplastic Large Cell Lymphoma

## General Management

- ECG and TTE to establish pre-chemotherapy cardiac function – many
    chemo regimens with anthracyclines
- Daily labs: CBC, TLS, LDH
- TLS prophylaxis: mIVF, allopurinol

## Common Chemotherapy Regimens for Lymphoma

<table>
<colgroup>
<col style="width: 25%" />
<col style="width: 50%" />
<col style="width: 25%" />
</colgroup>
<thead>
<tr class="header">
<th>Regimen</th>
<th>Components</th>
<th>Use</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>R-CHOP</td>
<td>Rituximab, cyclophosphamide, doxorubicin, vincristine,
prednisone</td>
<td>NHL</td>
</tr>
<tr class="even">
<td>R-EPOCH</td>
<td><p>Etoposide plus the drugs above</p>
<p>(dosing is different)</p></td>
<td><p>NHL</p>
<p>(Double/Triple hit)</p></td>
</tr>
<tr class="odd">
<td>Hyper-CVAD</td>
<td>Cyclophosphamide, vincristine, doxorubicin, and dexamethasone</td>
<td>NHL</td>
</tr>
<tr class="even">
<td>HD-MTX + R</td>
<td>High Dose methotrexate + Rituxumab</td>
<td>Primary CNS Lymphoma</td>
</tr>
<tr class="odd">
<td>ABVD</td>
<td>Doxorubicin, bleomycin, vinblastine, dacarbazine</td>
<td>HL</td>
</tr>
</tbody>
</table>
